Search for: "Janssen Ortho, LLC"
Results 1 - 20
of 34
Sorted by Relevance
|
Sort by Date
17 Feb 2020, 12:33 pm
Janseen Ortho LLC v. [read post]
29 Apr 2010, 2:06 am
Ortho-McNeil-Janssen has also agreed to a Corporate Integrity Agreement. [read post]
20 Jul 2010, 12:56 pm
In April of 2010, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, both subsidiaries of Johnson & Johnson, agreed to pay over $81 million to settle criminal and civil liability claims arising from the illegal promotion of the drug Topamax. [read post]
14 Jun 2015, 8:59 pm
Vintage Pharmaceuticals, LLC 1:15-cv-00429; filed May 28, 2015 in the District Court of Delaware Janssen Pharmaceuticals, Inc. v. [read post]
13 May 2010, 4:57 pm
Two subsidiaries of Johnson & Johnson, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc., have agreed to pay more than $81 million to settle allegations that they violated the False Claims Act by illegally promoting the epilepsy drug, Topomax. [read post]
2 May 2010, 6:32 pm
Ortho-McNeil Pharmaceutical LLC, agreed to pay a $6.14 mil criminal fine and plead guilty to a misdemeanor for misbranding Topamax in violation of the Food, Drug and Cosmetic Act. [read post]
12 Oct 2021, 5:12 pm
Janssen Ortho LLC v. [read post]
18 Nov 2011, 4:32 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. , No. 11-2070 (7th Cir. [read post]
6 Oct 2014, 4:41 pm
Xarelto History Xarelto is a Bayer drug that is marketed in the US by Johnson & Johnson and its subsidiary, Janssen Ortho LLC. [read post]
3 Nov 2006, 12:54 pm
Janssen Ortho LLC, No.05-2721. [read post]
29 Apr 2010, 1:26 pm
The settlement arose from two whistleblower cases filed under federal and state False Claims Acts, alleging that Otho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, Inc., improperly marketed Topamax for psychiatric uses, when it was only FDA-approved to treat epilepsy. [read post]
29 Apr 2010, 1:26 pm
The settlement arose from two whistleblower cases filed under federal and state False Claims Acts, alleging that Otho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, Inc., improperly marketed Topamax for psychiatric uses, when it was only FDA-approved to treat epilepsy. [read post]
31 Jan 2013, 7:30 am
Also on November 8, Research Affiliates, LLC and WisdomTree Investments, Inc. [read post]
26 Jun 2013, 6:30 am
Also on November 8, Research Affiliates, LLC and WisdomTree Investments, Inc. [read post]
1 Mar 2013, 6:28 am
Also on November 8, Research Affiliates, LLC and WisdomTree Investments, Inc. [read post]
4 Dec 2012, 6:30 am
Also on November 8, Research Affiliates, LLC and WisdomTree Investments, Inc. [read post]
30 Dec 2012, 3:30 am
Also on November 8, Research Affiliates, LLC and WisdomTree Investments, Inc. [read post]
25 May 2010, 7:54 am
Ortho-McNeil Pharmaceutical LLC, 10-CR-10147, US District Court, District of Massachusetts (Boston). [read post]
28 Aug 2009, 8:11 am
(patent infringement) 9/4: Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd., Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
2 Sep 2020, 1:45 pm
JOHNSON & JOHNSON d/b/a Alza Corporation, d/b/a Janssen Ortho LLC, d/b/a Janssen Research & Development LLC, d/b/a Ortho-McNeil Pharmaceuticals, Inc. [read post]
